Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT00568880 · COMPLETED
Trial details
- NCT number
- NCT00568880
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-08
- Primary completion
- 2011-06-22
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.